Skip to main content
editorial
. 2020 Jun 17;11(2):43. doi: 10.3390/jfb11020043

Figure 1.

Figure 1

Schematic representation of the interaction between Molecularly Imprinted Polymers (MIP)-based “monoclonal-type” plastic antibodies and SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).